Renuvion Safely and Effectively Treats Lax Skin in Trial
In a Phase II study, the Renuvion device improved the appearance of lax skin in 82.5% of subjects after 6 months.
In a Phase II study, the Renuvion device improved the appearance of lax skin in 82.5% of subjects after 6 months.
A new ISAPS report shows a facial procedure has overtaken liposuction as the most-performed surgery worldwide.
The new program is intended to offer practice partners incentives tied to purchases across its bio serums portfolio.